A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients | Zendy

Hans Furuland | Zendy; Torbjörn Linde | Zendy; J Ahlmén | Zendy; Anders Christensson | Zendy; Ulf Strömbom | Zendy; Bo G. Danielson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients

Author(s) -

Hans Furuland,

Torbjörn Linde,

J Ahlmén,

Anders Christensson,

Ulf Strömbom,

Bo G. Danielson

Publication year - 2003

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/18.2.353

Subject(s) - medicine , peritoneal dialysis , dialysis , erythropoietin , hemodialysis , kidney disease , epoetin alfa , adverse effect , randomized controlled trial , anemia , quality of life (healthcare) , gastroenterology , surgery , nursing

Partial correction of renal anaemia with erythropoietin improves quality of life (QoL). We aimed to examine if normalization of haemoglobin with epoetin alfa in pre-dialysis and dialysis patients further improves QoL and is safe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research